![Peter Andersen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Andersen
Président chez
IMMUNOVIA AB
Profil
Peter Høngaard Andersen was the founder of ACADIA Pharmaceuticals A, founded in 1997, where the title held was Vice President from 1997 to 1999.
Dr. Andersen was also the founder of Zealand Pharma A,Glycom A,EpiTherapeutics ApS,Prexton Therapeutics SA,InnovationsFonden..
Dr. Andersen previously served as Chairman-Research Directors Group at the European Federation of Pharmaceutical Industries & Assns since 2014.
The current roles also include Chairman at Immunovia AB since 2023, Chairman at Biotech Research & Innovation Centre, Director at Ossianix, Inc., Operating Partner at Forbion Capital Partners Management Holding BV since 2022, Member at Collegium Internationale Neuro-Psychopharmacologicum, and Member at Scandinavian Society for Psychopharmacology.
Former positions include Chairman at Lundbeck Research USA, Inc., Vice-Chairman at Scandion Oncology A in 2019, Chairman at Edvince AB, Director-Supervisory Board at to-BBB Holding BV, Director & Executive Vice President-Research at Lundbeck Pharma A from 2011 to 2014, Director at Serendex Pharmaceuticals A, Director at Imara, Inc., Director at Monsenso A, Project Manager-Metabolic Disease at Novo Nordisk A from 1984 to 1987, SVP-External Scientific Relations & Patents at H.
Lundbeck A, Member-Supervisory Board at to-BBB technologies BV, and Venture Partner at Ysios Capital Partners SGEIC SA from 2020 to 2023.
Education includes graduate and doctorate degrees from the University of Copenhagen.
Postes actifs de Peter Andersen
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOVIA AB | Président | 26/05/2023 |
Prexton Therapeutics SA
 Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Provides novel therapeutic compounds for treatment of Parkinson disease and other brain disorders | Fondateur | - |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Private Equity Investor | 20/07/2022 |
Biotech Research & Innovation Centre | Président | - |
Scandinavian Society for Psychopharmacology | Corporate Officer/Principal | 04/06/2010 |
Ossianix, Inc.
 Ossianix, Inc. Pharmaceuticals: GenericHealth Technology Develops single domain antibodies | Directeur/Membre du Conseil | - |
Collegium Internationale Neuro-Psychopharmacologicum | Corporate Officer/Principal | 04/06/2010 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Peter Andersen
| Sociétés | Poste | Fin |
|---|---|---|
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Private Equity Investor | 31/03/2023 |
| ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Peter Andersen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
47
Relations au 1er degré
26
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
Lundbeck Research USA, Inc.
 Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Zealand Pharma A/S
 Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forbion Capital Partners Management Holding BV
Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion is an active manager invest companies located in Northwest Europe and the United States. The firm focuses on companies operating in the fields of life sciences and biomedical technology. It participates in early stage capital requirements with an investment size ranging from EUR 1 - 7 million. It participates in follow-on investments, takes a board seat and acts as lead investor. | Finance |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services Operates as a trade association which promotes pharmaceutical discovery and development | Commercial Services |
to-BBB Holding BV
 to-BBB Holding BV Pharmaceuticals: GenericHealth Technology Operates as a holding company with interests in providing central nervous system drug technology to the pharmaceutical and biotechnology industries | Health Technology |
to-BBB technologies BV
 to-BBB technologies BV Pharmaceuticals: MajorHealth Technology Develops medicines for brain disease treatment | Health Technology |
Glycom A/S
 Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Health Technology |
Collegium Internationale Neuro-Psychopharmacologicum | |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Finance |
ACADIA Pharmaceuticals A/S
 ACADIA Pharmaceuticals A/S Miscellaneous Commercial ServicesCommercial Services Utilizies technology to fuel drug discovery and clinical development | Commercial Services |
EpiTherapeutics ApS
 EpiTherapeutics ApS Pharmaceuticals: MajorHealth Technology Develops cancer drugs based on epigenetics | Health Technology |
Immunovia AB
 Immunovia AB Pharmaceuticals: MajorHealth Technology Provides blood-based test for diagnosis of pancreatic cancer | Health Technology |
Lundbeck Pharma A/S
 Lundbeck Pharma A/S Medical DistributorsDistribution Services Engages in the production of drugs | Distribution Services |
Scandinavian Society for Psychopharmacology | |
Serendex Pharmaceuticals A/S
 Serendex Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Engages in the research and development of pharmaceuticals specifically for respiratory conditions | Health Technology |
Ossianix, Inc.
Ossianix, Inc. Pharmaceuticals: GenericHealth Technology Develops single domain antibodies | Health Technology |
Prexton Therapeutics SA
Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Provides novel therapeutic compounds for treatment of Parkinson disease and other brain disorders | Health Technology |
Biotech Research & Innovation Centre | |
InnovationsFonden
 InnovationsFonden Investment ManagersFinance Innovations Fonden invests in companies across the globe. The firm focuses on a broad range of sectors and industries. It participates in buyout transactions. | Finance |
Edvince AB
 Edvince AB Miscellaneous Commercial ServicesCommercial Services Engages in scientific and technological research & development activities | Commercial Services |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes novel therapeutics for patients with sickle cell disease | Health Technology |
Monsenso A/S
 Monsenso A/S Internet Software/ServicesTechnology Services Provides mobile health solutions for mental health can help in the prevention, early intervention and treatment of mental illness or behavioral disorders | Technology Services |
Scandion Oncology A/S
 Scandion Oncology A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for chemotherapy resistance mechanisms | Health Technology |
